Anzeige
Mehr »
Dienstag, 14.10.2025 - Börsentäglich über 12.000 News
Der Mann, der ein Lithium-Unternehmen im Wert von 1,2 Milliarden Dollar aufgebaut hat, ist zurück...
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PV0Q | ISIN: CA87975M2085 | Ticker-Symbol: 3D0A
Frankfurt
13.10.25 | 08:14
0,007 Euro
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
TELO GENOMICS CORP Chart 1 Jahr
5-Tage-Chart
TELO GENOMICS CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,0360,03808:15
0,0360,03807:30

Aktuelle News zur TELO GENOMICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
TELO GENOMICS Aktie jetzt für 0€ handeln
DoTelo Genomics Corp.: American Society of Hematology Accepts Telo Genomics' Abstract for Presentation at its 2025 Meeting and Exposition217Toronto, Ontario--(Newsfile Corp. - October 9, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for...
► Artikel lesen
01.10.Telo Genomics Corp (2): Telo Genomics relocates clinical laboratories2
30.09.Telo Genomics Corp.: Telo Genomics Expands Operations with Relocation of Clinical Laboratories to New, Larger Toronto Facility and Provides Board Update396Toronto, Ontario--(Newsfile Corp. - September 30, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for...
► Artikel lesen
30.09.Telo Genomics Corp (2): Telo Genomics 411,539 shares for debt3
19.09.Telo Genomics Corp.: Telo Genomics Highlights New MRD Methodology at The 2025 International Myeloma Society Meeting310Toronto, Ontario--(Newsfile Corp. - September 19, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for...
► Artikel lesen
08.09.Telo Genomics Corp.: Telo Geonomics Announces Engagement of Investor Relations Service Provider452Vancouver, British Columbia--(Newsfile Corp. - September 8, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") announces that it has engaged Hayden IR, LLC....
► Artikel lesen
05.08.Telo Genomics Corp.: Telo Genomics to Present at the OTCQB Venture Virtual Investor Conference472Toronto, Ontario--(Newsfile Corp. - August 5, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human...
► Artikel lesen
24.07.Telo Genomics Corp.: International Myeloma Society Accepts Telo Genomics' MRD Abstract for Presentation at Its 2025 Meeting381Toronto, Ontario--(Newsfile Corp. - July 24, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human...
► Artikel lesen
01.07.Telo Genomics Corp (2): Telo Genomics used by ex-president Louis over bonuses8
01.07.Telo Genomics Corp. to File Statement of Defence and Counterclaim to Lawsuit Filed by Former President378Toronto, Ontario--(Newsfile Corp. - June 30, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") has received a Statement of Claim filed by Sherif Louis, the...
► Artikel lesen
19.06.Telo Genomics Corp (2): Telo Genomics begins multiple myeloma clinical trial1
18.06.Telo Genomics Corp.: Telo Genomics Initiate Clinical Trial for Minimal Residual Disease in Multiple Myeloma429Toronto, Ontario--(Newsfile Corp. - June 18, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for human...
► Artikel lesen
28.05.Telo Genomics Corp (2): Telo Genomics enters client agreement with IPON4
27.05.Telo Genomics Corp.: Telo Genomics Receives New Client Tier under Intellectual Property Ontario (IPON)397Toronto, Ontario--(Newsfile Corp. - May 27, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human...
► Artikel lesen
15.05.Telo Genomics Corp.: European Hematology Association Accepts Abstract from Telo Genomics for Presentation at The 2025 Congress500Toronto, Ontario--(Newsfile Corp. - May 15, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human...
► Artikel lesen
10.04.Telo Genomics Corp.: Telo Genomics Announces Acceptance of its MRD Validation Data in Multiple Myeloma for ASCO 2025565Toronto, Ontario--(Newsfile Corp. - April 10, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for human...
► Artikel lesen
04.04.Telo Genomics Corp.: Telo Genomics Announces Appointment of John Farlinger to Its Board of Directors416Toronto, Ontario--(Newsfile Corp. - April 4, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") a leader in the development of diagnostic and prognostic tests...
► Artikel lesen
12.03.Telo Genomics Corp.: Telo Genomics Appoints Baechler Executive Chairman of The Board of Directors389Toronto, Ontario--(Newsfile Corp. - March 12, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") a leader in the development of diagnostic and prognostic tests...
► Artikel lesen
27.02.Telo Genomics Corp.: Telo Genomics Announces Expanded Partnership with Trusted Health Advisors573Toronto, Ontario--(Newsfile Corp. - February 27, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") announces that, further to its engagement with Trusted Health...
► Artikel lesen
23.12.24Telo Genomics Corp.: Telo Genomics Closes Oversubscribed $2.5 Million Private Placement723Toronto, Ontario--(Newsfile Corp. - December 23, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA) (the "Company" or "Telo") is pleased to announce that, further to its news release...
► Artikel lesen
Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1